Many Danaher Corporation ( NYSE:DHR ) insiders ditched their stock over the past year, which may be of interest to ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Washington, the District Of Columbia-based Danaher Corporation (DHR) designs, manufactures, and markets professional, medical ...

Danaher Corp (NYSE:DHR) on Tuesday reported first-quarter 2025 sales of $5.74 billion, down 1% year-over-year, beating the consensus of $5.59 billion. Non-GAAP core revenue was flat compared to the ...

Danaher's Q4 adjusted EPS missed estimates, while sales of $6.54B exceeded forecasts, driven by biotech and life sciences growth. The diagnostics segment saw a 3% decline, impacting overall earnings ...

On June 3, 2026, Danaher and its wholly owned subsidiary DH Masi Finance Inc. completed a private placement of senior unsecured notes totaling CHF 2.38 billion to institutional accredited investors, ...

We recently compiled a list of the 10 Best Industrial Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against the ...

Biotech funding has been in a down cycle for roughly the past four years. Higher interest rates, tighter capital markets, and a collapse in funding after 2021 forced a lot of early stage biotech ...

RGA Investment Advisors, an investment management company released its first quarter 2024 investor letter. A copy of the letter can be downloaded here. Strong economic growth combined with ...

Shareholders of Danaher Corp (Symbol: DHR) looking to boost their income beyond the stock's 0.5% annualized dividend yield can sell the January 2028 covered call at the $300 strike and collect the ...

If biotech funding continues to increase this year, Danaher could benefit.